MindOmics
ML-based Platform for Diagnosing Mental Illnesses
Health Tech & Life Sciences
Private
Company Overview
Snapshot
Founded in December 2022 by Ben-Zion Haddad and Uri Bertocchi, MindOmics operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on developing its core technology.
Business overview
MindOmics develops a SaaS platform that leverages advanced machine learning algorithms to accurately diagnose mental illnesses. The company's technology utilizes diverse data types to provide comprehensive and precise diagnoses, aiming to address the growing concern of misdiagnoses within the mental healthcare industry. MindOmics operates within the Health Tech & Life Sciences sector, specifically focusing on digital healthcare and digital medical diagnostics, targeting healthcare providers.
Log in to access full profile ›Company Intelligence Q&A
- What is MindOmics' primary focus?
- MindOmics focuses on developing a SaaS platform that utilizes machine learning algorithms for the accurate diagnosis of mental illnesses.
- When was MindOmics founded?
- MindOmics was founded in December 2022.
- Who are the founders of MindOmics?
- MindOmics was co-founded by Ben-Zion Haddad, who serves as CEO, and Uri Bertocchi, who serves as CTO.
- What problem does MindOmics aim to solve?
- MindOmics aims to tackle the issue of misdiagnoses in mental health, a significant concern within the healthcare industry, by providing more accurate diagnostic tools.
- In which sector does MindOmics primarily operate?
- MindOmics operates in the Health Tech & Life Sciences sector, with a specific focus on digital healthcare and digital medical diagnostics.